Heterogeneity of posterior limbic perfusion in very early Alzheimer's disease

Neuroscience Research

Volumn 55, Issue 3, 2006, Pages 285-291

  Nagao, Michinobu ^a   Sugawara, Yoshifumi ^a   Ikeda, Manabu ^a   Fukuhara, Ryuji ^a   Ishikawa, Tomohisa ^a   Murase, Kenya ^b   Kikuchi, Takanori ^a   Mochizuki, Teruhito ^a   Miki, Hitoshi ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Aging; Alzheimer's disease; Cerebral perfusion; Fractal dimension; SPECT

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN PERFUSION; CELL HETEROGENEITY; CONTROLLED STUDY; DEMENTIA; DISEASE SEVERITY; FEMALE; HUMAN; LIMBIC CORTEX; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PRIORITY JOURNAL; RADIOACTIVITY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THREE DIMENSIONAL IMAGING;

AGED; AGING; ALZHEIMER DISEASE; BRAIN MAPPING; CEREBRAL ARTERIES; CEREBRAL CORTEX; CEREBROVASCULAR CIRCULATION; DIAGNOSIS, DIFFERENTIAL; FEMALE; FRACTALS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LIMBIC SYSTEM; MALE; PREDICTIVE VALUE OF TESTS; REFERENCE VALUES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 33646767479     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2006.03.006     Document Type: Article

References (34)

1. Aftanas M.S., and Royce J.R. A factor analysis of brain damage tests administered to normal subjects with factor score comparisons across ages. Multivar. Behav. Res. 4 (1969) 459-481
2. Chetelat G., Desgranges B., de la Sayette V., Viader F., Eustache F., and Baron J.C. Mild cognitive impairment Can FDG-PET predict who is to rapidly convert to Alzheimer's disease. Neurology 60 (2003) 1374-1377
3. Cummings J.L., Mega M., Gray K., Rosenberg-Thompson S., Carusi D.A., and Gornbein J. The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 44 (1994) 2308-2314
4. Drayer B.P. Imaging of the aging brain. Part 1. Normal findings. Radiology 166 (1988) 785-796
5. Folstein M.F., Folstein S.E., and McHugh P.R. Mini-mental state: a practical method for grading the cognitive state of patients for clinician. J. Psychiat. Res. 12 (1975) 189-198
6. Foster N.L., Chase T., Mansi L., Brooks R., Fedio P., Patronas N.J., and Di Chiro G. Cortical abnormalities in Alzheimer's disease. Ann. Neurol. 16 (1984) 649-654
7. Haxby J., Duara R., Grandy C., Cutler N., and Rapaport S. Relations between neuropsychological and cerebral metabolic asymmetries in early Alzheimer's disease. J. Cereb. Blood Flow Metab. 5 (1985) 193-200
8. Holman B.L., Johnson K.A., Basem G., Carvalho P., and Satlin A. The scintigraphic appearance of Alzheimer's disease: a prospective study using Tc-99m HMPAO SPECT. J. Nucl. Med. 33 (1992) 181-185
9. Imabayashi E., Matsuda H., Asada T., Ohnishi T., Sakamoto S., Nakano S., and Inoue T. Superiority of 3-dimensional stereotactic surface projection analysis over visual inspection in discrimination of patients with very early Alzheimer's disease from controls using brain perfusion SPECT. J. Nucl. Med. 45 (2004) 1450-1457
10. Johnson K.A., Jones K., Holman B.L., Becker J.A., Spiers P.A., Satlin A., and Alber M.S. Preclinical prediction of Alzheimer's disease using SPECT. Neurology 50 (1998) 1563-1571
11. Kogure D., Matsuda H., Ohnishi T., Ohnishi T., Asada T., Uno M., Kunihiro T., Nakano S., and Takasaki M. Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT. J. Nucl. Med. 41 (2000) 1155-1162
12. Kokmen E., Beard C.M., O'Brien P.C., Offord K., and Kurland L.T. Is the incidence of dementing illness changing? A 25-year time-trend study in Rochester, MN (1960-1984). Neurology 43 (1993) 1887-1892
13. Kuhl D.E., Metter E.J., Riege W.H., and Phelps M.E. Effects of human aging on patterns of local cerebral glucose utilization determined by the [18F] fluorodeoxyglucose method. J. Cereb. Blood Flow Metab. 2 (1982) 163-171
14. Lawton M.P., and Brody E.M. Assessment of older people: self-maintaning and instrumental activities of daily living. Gerontologist 9 (1969) 179-186
15. Mandelbrot B. How long is the coast of Britain? Statistical self-similarity and fractal dimension. Science 156 (1967) 636-638
16. Maruyama M., Arai H., Sugita M., Tanji H., Higuchi M., Okamura N., Matsui T., Higuchi S., Matsushita S., Yoshida H., and Sasaki H. Cerebrospinal fluid amyloid beta (1-42) levels in the mild cognitive impairment stage of Alzheimer's disease. Exp. Neurol. 172 (2001) 433-436
17. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 (1984) 939-944
18. Messa C., Perani D., Lucignani G., Zenorini A., Zito F., Rizzo G., Grassi F., Del Sole A., Franceschi M., and Gilardi M.C. High-resolution technetium-99m HMPAO SPECT in patients with probable Alzheimer's disease: comparison with fluorine-18-FDG-PET. J. Nucl. Med. 35 (1994) 210-216
19. Minoshima S., Foster N.L., and Kuhl D.E. Posterior cingulate cortex in Alzheimer's disease. Lancet 344 (1994) 895
20. Minoshima S., Giordani B., Berent S., Frey K.A., Foster N.L., and Kuhl D.E. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann. Neurol. 42 (1997) 85-94
21. Moeller J.R., Ishikawa T., Dhawan V., Spetsieris P., Mandel F., Alexander G.E., Grandy C., Pietrini P., and Eidelberg D. The metabolic topography of normal aging. J. Cereb. Blood Flow Metab. 16 (1996) 385-398
22. Mohs R.C., Rosen W.G., and Davis K.L. The Alzheimer's disease assessment scale: an instrument for assessing treatment efficacy. Psychopharmacol. Bull. 19 (1983) 448-450
23. Morris J.C. The clinical dementia rating (CDR): current version and screening rules. Neurology 43 (1993) 2412-2414
24. Mozley P.D., Sadek A.M., Alavi A., Gur R.C., Muenz L.R., Bunow B.J., Kim H.J., Stecker M.H., Jolles P., and Newberg A. Effects of aging on the cerebral distribution of technetium-99m hexamethylpropylene amine oxime in healthy humans. Eur. J. Nucl. Med. 24 (1997) 754-761
25. Nagao M., Murase K., Kikuchi T., Ikeda M., Nebu A., Fukuhawa R., Sugawara Y., Miki H., and Ikezoe J. Fractal analysis of cerebral blood flow distribution in Alzheimer's disease. J. Nucl. Med. 42 (2001) 1445-1450
26. Nagao M., and Murase K. Measurement of heterogeneous distribution on Technegas SPECT images by three-dimensional fractal analysis. Ann. Nucl. Med. 16 (2002) 369-376
27. Nagao M., Sugawara Y., Ikeda M., Fukuhara R., Hokoishi K., Murase K., Mochizuki T., Miki H., and Kikuchi T. Heterogeneity of cerebral blood flow in frontotemporal lobar degeneration and Alzheimer's disease. Eur. J. Nucl. Med. 31 (2004) 162-168
28. Nebu A., Ikeda M., Fukuhara R., Shigenobu K., Maki N., Hokoishi K., Komori K., Yasuoka T., and Tanabe H. Relationship between blood flow kinetics and severity of Alzheimer's disease: assessment of severity using a questionnaire-type examination, Alzheimer's disease assessment scale, cognitive sub-scale (ADAScog). Dement. Geriatr. Cogn. Disord. 12 (2001) 318-325
29. Nelson T. Fractal physiologic complexity, scaling, and opportunities for imaging. Invest. Radiol. 25 (1990) 1140-1148
30. Nestor P.J., Fryer T.D., Smielewski P., and Hodges J.R. Limbic hypometabolism in Alzheimer's disease and mild cognitive impairment. Ann. Neurol. 54 (2003) 343-351
31. Petersen R.C., Smith G.E., Ivnik R.J., Kokmen E., and Tangalos E.G. Memory function in very early Alzheimer's disease. Neurology 44 (1994) 867-872
32. Petit-Taboue M.C., Landeau B., Desson J.F., Desgranges B., and Baron J.C. Effects of healthy aging on the regional cerebral metabolic rate of glucose assessed with statistical parametric mapping. Neuroimage 7 (1998) 176-184
33. Yoshikawa T., Murase K., Oku N., Kitagawa K., Imaizumi M., Takasawa M., Rishu P., Hashikawa K., Nishikawa T., Hori M., and Matsumoto M. Quantification of the heterogeneity of cerebral blood flow in vascular dementia. J. Neurol. 250 (2003) 194-200
34. Yoshikawa T., Murase K., Oku N., Kitagawa K., Imaizumi M., Takasawa M., Nishikawa T., Matsumoto M., Hatazawa J., and Hori M. Statistical image analysis of cerebral blood flow in vascular dementia with small-vessels disease. J. Nucl. Med. 44 (2003) 505-511